These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2438923)

  • 1. A multicenter dose-response study of pirmenol hydrochloride in patients with ventricular premature contractions.
    Farnham DJ
    Am J Cardiol; 1987 Jun; 59(16):43H-47H. PubMed ID: 2438923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of pirmenol hydrochloride in suppressing high frequency ventricular ectopy: a placebo-controlled, double-blind, multicenter study.
    Báguena Candela J
    Am J Cardiol; 1987 Jun; 59(16):48H-52H. PubMed ID: 2438924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations.
    de Buitleir M; Crevey BJ; Johnson T; Kou WH; Nelson SD; Schmaltz S; Morady F
    Am Heart J; 1988 Aug; 116(2 Pt 1):379-84. PubMed ID: 2456681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug.
    Garg DC; Jallad NS; Singh S; Ng KF; Weidler DJ
    J Clin Pharmacol; 1988 Sep; 28(9):812-7. PubMed ID: 2466056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic efficacy of pirmenol in the treatment of premature ventricular complexes.
    Toivonen LK; Nieminen MS; Manninen V; Frick MH
    Eur Heart J; 1985 Sep; 6(9):737-44. PubMed ID: 2416566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study of pirmenol in the treatment of ventricular arrhythmias.
    Gimeno Gascon JV; Algarra Vidal FJ
    Am J Cardiol; 1987 Jun; 59(16):53H. PubMed ID: 3591713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oral pirmenol in suppressing ventricular premature depolarisations.
    de Buitleir M; Crevey B; Johnson T; Baerman J; Morady F
    Ir Med J; 1987 Feb; 80(2):60-3. PubMed ID: 2435676
    [No Abstract]   [Full Text] [Related]  

  • 8. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study.
    Anderson JL; Lutz JR; Nappi JM
    Am J Cardiol; 1984 Feb; 53(4):522-7. PubMed ID: 6198894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cifenline in the short-term treatment of patients with ventricular premature complexes: a double-blind placebo-controlled study.
    Kostis JB; Davis D; Kluger J; Aogaichi K; Smith M
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):88-95. PubMed ID: 2475722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
    Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
    Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical and clinical pharmacokinetics of pirmenol.
    Chang T
    Am J Cardiol; 1987 Jun; 59(16):15H-19H. PubMed ID: 2438922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation of the kinetics of pirmenol to its antiarrhythmic efficacy.
    Johnson BF; Haffajee CI; Woodman T; Sloan KL
    J Clin Pharmacol; 1988 May; 28(5):401-5. PubMed ID: 3392237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias.
    Hampton EM; Anderson JL; Lutz JR; Nappi JM
    Eur J Clin Pharmacol; 1986; 31(1):15-22. PubMed ID: 3780822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirmenol in the long-term treatment of chronic ventricular arrhythmias: a placebo-controlled study.
    Toivonen LK; Nieminen MS; Manninen V; Frick MH
    J Cardiovasc Pharmacol; 1986; 8(1):156-60. PubMed ID: 2419679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
    Muhiddin KA; Turner P; Hellestrand K; Camm AJ
    Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethmozine for ventricular premature complexes.
    Gear K; Marcus FI; Huang SK; Fenster PE; Appleton C; Moeller V; Renaud G; Serokman R
    Am J Cardiol; 1986 Apr; 57(11):947-9. PubMed ID: 2421571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety, and pharmacokinetics of a concentration-maintaining regimen of intravenous pirmenol.
    Reiter MJ; Hammill SC; Shand DG; Verghese C; McCarthy E; Pritchett EL
    Am J Cardiol; 1983 Jul; 52(1):83-7. PubMed ID: 6858934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics and pharmacokinetics of oral pirmenol.
    Ellenbogen KA; Roark SF; Sintetos AL; Smith MS; McCarthy EA; Smith WM; Kates RE; Pritchett EL
    Clin Pharmacol Ther; 1987 Oct; 42(4):405-10. PubMed ID: 3665339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine.
    Salerno DM; Fifield J; Farmer C; Hodges M
    Clin Cardiol; 1991 Jan; 14(1):25-32. PubMed ID: 2019027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study.
    Toivonen LK; Nieminen MS; Manninen V; Frick MH
    Br Heart J; 1986 Feb; 55(2):176-80. PubMed ID: 3510642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.